Interleukin-6 and obesity: The crosstalk between intestine, pancreas and liver

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 16, Issue 5, 2013, Pages 564-568

  El Kadre, Luciana J ^a   Tinoco, Augusto C A ^a  

^a Saõ José Do Aval Hospital   (Brazil)

Author keywords

diabetes; exercise; interleukin 6; muscle; obesity

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INTERLEUKIN 6;

ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INNATE IMMUNITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE; LIVER; METABOLIC REGULATION; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS; REVIEW;

EID: 84883294068     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32836410e6     Document Type: Review

References (34)

1. Arora P, Garcia-Bailo B, Dastani Z, et al. Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes. BMC Med Genet 2011; 12:95.
2. Rajendran K, Devarajan N, Ganesan M, Ragunathan M. Obesity, inflammation and acute myocardial infarction: Expression of leptin, IL-6 and high sensitivity-CRP in Chennai based population. Thromb J 2012; 10:13.
3. Gruys E, Toussaint MJ, Niewold TA, Koopmans SJ. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B 2005; 6:1045-1056.
4. Celik IH, Yilmaz Y, Erdeve O, et al. The acute-phase response in differentiating sepsis from inflammation in neonates who require abdominal surgery. Acta Chirurgica Belgica 2012; 112:292-296.
5. Barnes TC, Anderson ME, Moots RJ. The many faces of interleukin-6: The role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis. Int J Rheumatol 2011; 2011:721608.
6. Macotela Y, Emanuelli B, Mori MA, et al. Intrinsic differences in adipocyte precursor cells from different white fat depots. Diabetes 2012; 61:691-699.
7. Smorlesi A Frontini A Giordano A Cinti S. The adipose organ: White-brown adipocyte plasticity and metabolic inflammation. Obesity Rev 2012; 13 (Suppl 2):83-96.
8. Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 2012; 18:363-374.
9. Vatier C, Kadiri S, Muscat A, et al. Visceral and subcutaneous adipose tissue from lean women respond differently to lipopolysaccharide-induced alteration of inflammation and glyceroneogenesis. Nutr Diabetes 2012; 2:e51.
10. Sun S, Ji Y, Kersten S, Qi L. Mechanisms of inflammatory responses in obese adipose tissue. Annu Rev Nutr 2012; 32:261-286.
11. Finucane OM, Reynolds CM, McGillicuddy FC, Roche HM. Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance. Proc Nutr Soc 2012; 71:622-633.
12. Guzman-Flores JM, Lopez-Briones S. Cells of innate and adaptive immunity in type 2 diabetes and obesity]. Gaceta medica de Mexico 2012; 148:381-389.
13. Rocha VZ, Folco EJ. Inflammatory concepts of obesity. Int J Inflamm 2011; 2011:529061.
14. Stolzman S, Bement M. Inflammatory markers in pediatric obesity. ICAN 2012; 297-302.
15. Czyzewska J, Wasilewska K, Kaminska J, et al. Assess the impact of concentrations of inflammatory markers IL-6, CRP in the presence of albuminuria in patients with type 2 diabetes. Pol Merkur Lekarski 2012; 32:98-102.
16. Fisman EZ, Tenenbaum A. The ubiquitous interleukin-6: A time for reappraisal. Cardiovasc Diabetol 2010; 9:62.
17. Holmes A. Role of Interleukin-6 in states of metabolic health and disease: RMIT University; 2006.
18. Martin-Cordero L, Garcia JJ, Hinchado MD, Ortega E. The interleukin-6 and noradrenaline mediated inflammation-stress feedback mechanism is dysregulated in metabolic syndrome: Effect of exercise. Cardiovasc Diabetol 2011; 10:42.
19. Pedersen BK. Muscles and their myokines. J Exp Biol 2011; 214 (Pt 2):337-346.
20. Pedersen BK, Febbraio M. Muscle-derived interleukin-6: A possible link between skeletal muscle, adipose tissue, liver, and brain. Brain Behav Immun 2005; 19:371-376.
21. Liu Y, Lin J. Blocking the IL-6-STAT3 signaling pathway: Potential liver cancer therapy. Future Oncol 2011; 7:161-164.
22. Benrick A, Wallenius V, Asterholm IW. Interleukin-6 mediates exerciseinduced increase in insulin sensitivity in mice. Exp Physiol 2012; 97:1224-1235.
23. Mavros Y, Kay S, Anderberg KA, et al. Changes in insulin resistance and HbA1c are related to exercise-mediated changes in body composition in older adults with Type 2 diabetes interim outcomes from the GREAT2DO trial. Diabetes Care 2013. [Epub ahead of print]
24. Pedersen BK, Febbraio M. Muscle as an endocrine organ: Focus on musclederived interleukin-6. Physiol Rev 2008; 88:.
25. Kinoshita T, Nakamura T, Umemoto Y, et al. Increase in interleukin-6 immediately after wheelchair basketball games in persons with spinal cord injury: Preliminary report. Spinal Cord 2013; 51:508-510.
26. Febbraio MA. Gp130 receptor ligands as potential therapeutic targets for obesity. J Clin Investig 2007; 117:841-849.
27. Ellingsgaard H, Hauselmann I, Schuler B, et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 2011; 17:1481-1489.
28. Habener JF, Stanojevic V. Alpha-cell role in beta-cell generation and regeneration. Islets 2012; 4:188-198.
29. Thorel F, Nepote V, Avril I, et al. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 2010; 464:1149-1154.
30. Johnson AM, Olefsky JM. The origins and drivers of insulin resistance. Cell 2013; 152:673-684.
31. Habener JF, Stanojeviv V. Alpha cells come of age. Trends Endocrinol Metab 2012; 24:153-163.
32. Thorel F, Né pote V, Avril A. Conversion of adult pancreatic a-cells to b-cells after extreme b-cell loss. Nature 2010; 464:1149-1154.
33. da Silva Krause M, Bittencourt A, Homem de Bittencourt PI Jr, et al. Physiological concentrations of interleukin-6 directly promote insulin secretion, signal transduction, nitric oxide release, and redox status in a clonal pancreatic beta-cell line and mouse islets. J Endocrinol 2012; 214:301-311.
34. Fernandez-Millan E, de Toro-Martin J, Lizarraga-Mollinedo E, et al. Role of endogenous IL-6 in the neonatal expansion and functionality of Wistar rat pancreatic alpha cells. Diabetologia 2013. doi:10.1007/s00125-013-2862-8.